Sorrento Therapeutics Inc (NASDAQ:SRNE)
| 1.00 Delayed Data As of Jan 27 |  0.00 / 0.00%Today’s Change | 0.74 Today|||52-Week Range 3.60 | +12.87% Year-to-Date |
Latest SRNE News | Press Releases
No recent news for Sorrento Therapeutics Inc.
Today’s Trading
| Previous close | 1.00 |
| Today’s open | 0.98 |
| Day’s range | 0.96 - 1.06 |
| Volume | 499,229 |
| Average volume (3 months) | 9,410,297 |
| Market cap | $507.3M |
Data as of 4:00pm ET, 01/27/2023
Growth & Valuation
| Earnings growth (last year) | -11.89% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | +32.31% |
| P/E ratio | NM |
| Price/Sales | 25.91 |
| Price/Book | 4.29 |
Competitors
| ---- | ||
| KZRKezar Life Sciences ... | +0.18 | +2.75% |
| NKTRNektar Therapeutics | +0.15 | +5.89% |
| ATRAAtara Biotherapeutic... | +0.01 | +0.19% |
Data as of 4:00pm ET, 01/27/2023
Financials
| Next reporting date | March 9, 2023 |
| EPS forecast (this quarter) | -$0.23 |
| Annual revenue (last year) | $52.9M |
| Annual profit (last year) | -$428.3M |
| Net profit margin | -809.63% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
